Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
Remora Capital Corporation issued 106,974.359 shares of common stock to investors at a price of $9.75 per share. The private placement resulted in aggregate proceeds of approximately $1.043 million and was conducted under a Section 4(a)(2) exemption.
QuantumScape announced a strategic ecosystem partnership with Muehlbauer Group to provide cell assembly equipment for a planned 100 megawatt-hour (MWh) commercial-scale mass production line. The partnership aims to scale QuantumScape's solid-state cell technology from the current Eagle Line pilot phase toward gigawatt-hour scale production, with the 100-MWh line targeted for 2028.
Ares Sports, Media & Entertainment Opportunities Capital Raise of $77M
Ares Sports, Media and Entertainment Opportunities LP sold unregistered limited partnership units for aggregate consideration of approximately $77.0 million on October 1, 2026. The sale was part of the Fund's continuous private offering, which has raised approximately $988 million in total cash consideration to date.
Professional Diversity Network entered into securities purchase agreements to sell 146,713 shares of common stock in a private placement for gross proceeds of approximately $250,000. The shares are priced at $1.704 per share, representing a 40% discount to the recent closing price, with the closing expected to occur on or around November 3, 2026.
Ionis Pharmaceuticals' partner GSK received FDA approval for HIBSAGO (bepirovirsen) for the treatment of chronic hepatitis B (CHB) in adult patients without cirrhosis. The approval, granted under priority review and Breakthrough Therapy Designation, is based on Phase 3 B-Well trials showing a 19% functional cure rate compared to less than 1% for standard of care. Ionis is eligible to receive regulatory and sales milestone payments plus tiered royalties of 10-12% on net sales.
Valor Energy Inc received a deficiency notice from Nasdaq for failing to meet the minimum stockholders' equity requirement of $2.5 million. The company reported a stockholders' deficit of $35.3 million as of June 30, 2026, primarily due to the classification of warrants as derivative liabilities. The company has 45 days to submit a plan to regain compliance.
KKR FS Income Trust Select issued and sold 136,926.789 Class I shares for aggregate consideration of approximately $3.404 million on October 1, 2026. The sale was part of the company's ongoing continuous private offering, which has raised approximately $1.045 billion to date against a $5.0 billion target.
KKR FS Income Trust issued and sold 146,235.262 Class I shares for aggregate consideration of approximately $4.259 million on October 1, 2026. The sale was part of the company's ongoing continuous private offering, which has raised approximately $1.773 billion to date against a $5.0 billion target.
First Mid Bancshares M&A Deal with EPL LINCO Trust
First Mid Bancshares, Inc. entered into an amendment to a registration rights agreement with EPL LINCO Trust and PL Generations LLC. The amendment facilitates the potential secondary resale of shares previously issued as consideration for the acquisition of LINCO Bancshares, Inc. by adding PL Generations as a permitted transferee.
Stone Point Credit Income Fund Capital Raise of $41.2M
Stone Point Credit Income Fund issued and sold approximately 1.66 million common shares through capital drawdown notices to investors, raising total proceeds of approximately $41.18 million. The shares were sold at a net asset value of $24.7338 per share to investors under existing subscription agreements. To date, the Fund has received total capital commitments of $1.19 billion, with approximately $736.5 million remaining unfunded.
Group 1 Automotive Signs $1.3B M&A Deal with Hennessy Automobile Companies, Inc.
Group 1 Automotive completed the acquisition of 10 automobile dealerships and one collision center in the Atlanta, Georgia market from Hennessy Automobile Companies for approximately $1.3 billion. The deal was funded through a combination of cash on hand and $1.25 billion in senior notes issued in a private placement. The acquisition includes related real estate and leasehold interests, with $80 million of the purchase price held in escrow for indemnification obligations.
CarMax Auto Owner Trust 2026-4 Capital Raise of $1.33B
CarMax Auto Owner Trust 2026-4 completed the issuance of $1,333,122,000 in asset-backed notes across multiple classes (A-1 through D). The transaction involved the transfer of motor vehicle retail installment sale contracts from CarMax Business Services to the trust to serve as collateral for the securities.
Abbott Laboratories announced its intention to separate its global Nutrition business into an independent, publicly traded company via a tax-free distribution to shareholders. The new entity will be a global leader in healthy nutrition with approximately $8.5 billion in annual sales and a portfolio including brands like Similac, Ensure, and PediaSure. The separation is expected to be completed by the end of 2027.
“As we continue to shape Abbott for the future, this separation will benefit both companies, setting each one up for maximum success in its respective market. Our Nutrition business has a unique opportunity to capitalize on the growing demand for healthy nutrition, and it will be better positioned as an independent company to more effectively direct its strategic resources across its priorities.”
Robert B. Ford, chairman and chief executive officer, Abbott
Smith & Wesson Brands Signs $165M M&A Deal with Savage Arms
Smith & Wesson Brands, Inc. acquired Savage Arms from JDH Capital for an adjusted transaction value of approximately $164.9 million. The consideration consisted of $42.4 million in cash and 8,993,968 shares of common stock, making JDH Capital the company's largest stockholder. The deal meaningfully expands Smith & Wesson's presence in the hunting and bolt-action rifle categories.
Value
$165M
Counterparty
Savage Arms
“The acquisition of Savage is a transformative step for Smith & Wesson and an important milestone in our strategy to be the undisputed market leader in the firearm industry. Savage’s brand heritage, culture, and longstanding reputation for performance and innovation align closely with our own, and the business meaningfully expands our presence in the hunting category. By bringing these two companies together, we have created a broader, stronger platform with significant opportunities to better serve our customers, accelerate innovation, realize operating efficiencies and drive long-term value for our stockholders.”
Mark Smith, President and Chief Executive Officer of Smith & Wesson
Consolidated Water Co M&A Deal with Honolulu Board of Water Supply
Consolidated Water provided a status and timeline update for its Kalaeloa seawater desalination project in Hawaii, noting that construction is now expected to begin in the first half of 2027 due to permitting delays. The project recently received key approvals from the State Historic Preservation Division and the Hawaii Department of Health, and the Honolulu Board of Water Supply has granted schedule extensions and authorized $6 million for long-lead equipment procurement.
Elmet Group Partnership with Blue Moon Metals Inc.
Elmet Group Co. entered into a strategic partnership with Blue Moon Metals Inc. involving an equity investment and board representation to support the development of the Springer Tungsten Complex in Nevada. Elmet purchased 3,500,000 units at CAD 10.00 per unit, with each unit consisting of one common share and one purchase warrant, and entered into an Investor Rights Agreement granting Elmet the right to nominate one director to the Blue Moon Board.
NextTrip Partnership with The Travel Agent Next Door Inc.
NextTrip entered into a joint venture agreement with The Travel Agent Next Door (TTAND) to launch JOURNYGO Travel in Canada. The partnership combines NextTrip's JOURNY TV media content with TTAND's network of 1,850 agents to provide travel booking and fulfillment, with NextTrip receiving a share of booking commissions.
Imunon Divestiture to VoxelDox Therapeutics, Inc. for $16.5M
Imunon entered into an asset purchase agreement to sell its ThermoDox assets to VoxelDox Therapeutics, which intends to develop the drug for glioblastoma. Imunon will receive a 4.76% equity stake in VoxelDox, up to $16.5 million in clinical and regulatory milestone payments, and royalties on future net sales. The closing is contingent on VoxelDox raising at least $2.5 million in financing.
UDR, Inc. announced the formation of a long-term strategic joint venture with Apollo involving a diversified portfolio of 19 apartment communities totaling 7,059 homes. The portfolio contributed by UDR is valued at approximately $2.0 billion, and the company simultaneously raised its full-year 2026 guidance for Net Income and FFOA.
Getty Images Holdings, Inc. and several subsidiaries filed voluntary petitions for Chapter 11 bankruptcy protection in the District of Delaware to implement a prepackaged reorganization plan. The restructuring is supported by a previously announced agreement with majority shareholders and lenders to recapitalize the company's funded indebtedness. The company has filed first-day motions to continue ordinary operations, including payments to employees, vendors, and content contributors.
Cencora Signs $2.4B M&A Deal with American Oncology Network, Inc.
Cencora has signed a definitive agreement to acquire American Oncology Network (AON) for an enterprise value of $2.4 billion, including $2.3 billion at closing and up to $100 million in contingent value rights. The acquisition expands Cencora's oncology management services organization (MSO) platform by adding a network of over 350 oncology providers across 21 states.
Pine Tree Acquisition Corp. announced that holders of its units from its initial public offering may elect to separately trade the underlying Class A ordinary shares and rights starting October 23, 2026. The separated securities will list on Nasdaq under the symbols 'PAXG' and 'PAXGR', while unseparated units will continue to trade under 'PAXGU'.
Soluna Holdings Partnership with Applied Digital Corporation
Soluna Holdings has entered into a definitive agreement to form a jointly owned company with Applied Digital Corporation to develop a 50 MW AI and HPC data center at Project Dorothy 3 in Texas. Applied Digital will hold a 51% interest and provide capital, while Soluna will hold 49% and contribute land and project assets. Additionally, ChronoScale Holdings has signed a letter of intent to lease the planned facility under a triple-net lease arrangement.
Worthington Steel issued a status update regarding its pending Domination and Profit and Loss Transfer Agreement (DPLTA) with Klöckner & Co SE ahead of an extraordinary general meeting. The company stated that if the DPLTA vote does not achieve the required 75% majority, it will not pursue another vote for at least one year.
Roivant and its subsidiary Priovant Therapeutics announced positive results from the Phase 3 CLARITY program evaluating brepocitinib in non-infectious uveitis (NIU). The drug met its primary and all key secondary endpoints in two identical trials, demonstrating a median time to treatment failure of over 48 weeks compared to 12 weeks for placebo, and the company plans to file a supplemental New Drug Application (sNDA) in the first half of 2027.
Genprex highlighted peer-reviewed preclinical research published in Mechanisms of Ageing and Development regarding the TUSC2 gene, which is the therapeutic component of its REQORSA oncology program. The study found that TUSC2 deficiency in mice leads to mitochondrial dysfunction and protein homeostasis collapse in the brain, with human datasets showing TUSC2 expression also declines with age and Alzheimer's disease. While exploratory, the findings suggest TUSC2 plays a foundational role in brain health beyond its established role in cancer treatment.
Vivos Therapeutics received a letter from Nasdaq confirming that the company has regained compliance with the minimum stockholders' equity requirement of $2.5 million under Listing Rule 5550(b)(1). The compliance was achieved following a transaction involving the issuance of Series C Convertible Preferred Stock, which is expected to increase stockholders' equity by more than $10 million. The company must continue to evidence compliance in its next periodic report to avoid potential delisting.
Apex Tech Acquisition Signs $3.5B M&A Deal with Korai Flix, Inc.
APEX Tech Acquisition Inc. (a SPAC) has entered into a definitive merger agreement to acquire Korai Flix, Inc., an AI-powered interactive online entertainment platform, in a deal valuing Korai at $3.5 billion on a pre-money equity basis. Upon closing, the combined entity will be renamed Krflix Group, Inc. and is expected to list on the NYSE. The transaction is projected to close in the first quarter of 2027, subject to shareholder and regulatory approvals.
Nova Minerals Signs $3.5B M&A Deal with Korai Flix Inc.
APEX Tech Acquisition Inc. (NYSE: TRAD) has entered into a definitive merger agreement to acquire Korai Flix Inc., an AI-powered interactive online entertainment platform, in a deal valuing Korai at $3.5 billion on a pre-money equity basis. Upon closing, expected in Q1 2027, the combined company will be renamed Krflix Group Inc. and is expected to list on the NYSE.
Silicon Valley Acquisition Signs $5M M&A Deal with EigenQ, Inc.
Silicon Valley Acquisition Corp. (SVAQ) provided an update on its pending merger with EigenQ, Inc., specifically announcing a subordinated unsecured note financing. SVAQ and EigenQ entered into an agreement with an investor for the issuance of up to $5 million in promissory notes and warrants to support the transaction. This financing is part of the broader capital structure required to complete the previously announced business combination.